A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to obtain a first clinical assessment of the safety of
dersalazine sodium in ulcerative colitis patients with mild to moderate disease.